Literature DB >> 30713160

A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor α.

Jérôme Eberhardt1, Alastair G McEwen1, William Bourguet2, Dino Moras1, Annick Dejaegere1.   

Abstract

The retinoic X receptor (RXR) plays a crucial role in the superfamily of nuclear receptors (NRs) by acting as an obligatory partner of several nuclear receptors; its role as a transcription factor is thus critical in many signalling pathways, such as metabolism, cell development, differentiation and cellular death. The first published structure of the apo ligand-binding domain (LBD) of RXRα, which is still used as a reference today, contained inaccuracies. In the present work, these inaccuracies were corrected using modern crystallographic tools. The most important correction concerns the presence of a π-bulge in helix H7, which was originally built as a regular α-helix. The presence of several CHAPS molecules, which are visible for the first time in the electron-density map and which stabilize the H1-H3 loop, which contains helix H2, are also revealed. The apo RXR structure has played an essential role in deciphering the molecular mode of action of NR ligands and is still used in numerous biophysical studies. This refined structure should be used preferentially in the future in interpreting experiments as well as for modelling and structural dynamics studies of the apo RXRα LBD.

Entities:  

Keywords:  ligand binding domains; nuclear receptors; retinoic X receptor α; retinoic acid

Mesh:

Substances:

Year:  2019        PMID: 30713160      PMCID: PMC6360438          DOI: 10.1107/S2053230X18018022

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  33 in total

1.  Structural and functional characterization of pi bulges and other short intrahelical deformations.

Authors:  Jean-Philippe Cartailler; Hartmut Luecke
Journal:  Structure       Date:  2004-01       Impact factor: 5.006

2.  Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level.

Authors:  Yann Brelivet; Sabrina Kammerer; Natacha Rochel; Olivier Poch; Dino Moras
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

3.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

Review 4.  Allosteric controls of nuclear receptor function in the regulation of transcription.

Authors:  Isabelle Billas; Dino Moras
Journal:  J Mol Biol       Date:  2013-03-15       Impact factor: 5.469

5.  Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.

Authors:  W Bourguet; V Vivat; J M Wurtz; P Chambon; H Gronemeyer; D Moras
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

6.  The dual role of CHAPS in the crystallization of stromelysin-3 catalytic domain.

Authors:  Anne-Laure Gall; Marc Ruff; Dino Moras
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-02-21

7.  Hepatocyte nuclear factor 4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms.

Authors:  J Eeckhoute; E Moerman; T Bouckenooghe; B Lukoviak; F Pattou; P Formstecher; J Kerr-Conte; B Vandewalle; B Laine
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

Review 8.  RAR and RXR modulation in cancer and metabolic disease.

Authors:  Lucia Altucci; Mark D Leibowitz; Kathleen M Ogilvie; Angel R de Lera; Hinrich Gronemeyer
Journal:  Nat Rev Drug Discov       Date:  2007-10       Impact factor: 84.694

Review 9.  International Union of Pharmacology. LXIII. Retinoid X receptors.

Authors:  Pierre Germain; Pierre Chambon; Gregor Eichele; Ronald M Evans; Mitchell A Lazar; Mark Leid; Angel R De Lera; Reuben Lotan; David J Mangelsdorf; Hinrich Gronemeyer
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  2 in total

1.  A molecular switch regulating transcriptional repression and activation of PPARγ.

Authors:  Jinsai Shang; Sarah A Mosure; Jie Zheng; Richard Brust; Jared Bass; Ashley Nichols; Laura A Solt; Patrick R Griffin; Douglas J Kojetin
Journal:  Nat Commun       Date:  2020-02-19       Impact factor: 14.919

2.  Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.

Authors:  Zahra Heidari; Ian M Chrisman; Michelle D Nemetchek; Scott J Novick; Anne-Laure Blayo; Trey Patton; Desiree E Mendes; Philippe Diaz; Theodore M Kamenecka; Patrick R Griffin; Travis S Hughes
Journal:  Nat Commun       Date:  2019-12-20       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.